Jasper Therapeutics, Inc. — Director's Dealing 2021

Oct 1, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Jasper Therapeutics, Inc. (JSPR)
CIK: 0001788028
Period of Report: 2021-09-24

Reporting Person: Qiming U.S. Healthcare Fund II, L.P. (10% Owner)
Reporting Person: Qiming U.S. Healthcare GP II, LLC (10% Owner)
Reporting Person: MCDADE MARK (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Voting Common Stock	5852982	Direct

Footnotes

F1: The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. ("Qiming"). The general partner of Qiming is Qiming U.S. Healthcare GP II, LLC ("Qiming GP"). Gary Rieschel and Mark McDade are the managing partners of Qiming GP. Each of Qiming GP, Mr. Rieschel and Mr. McDade may be deemed to beneficially own the shares owned by Qiming.